
Simponi50 mg/0.5
Unimed Unihealth MFG. Ltd.
Golimumab is a human monoclonal antibody (TNF-alpha inhibitor) approved for the following conditions: Moderate-to-severe active rheumatoid arthritis (RA) in adults and more.
Golimumab is a human monoclonal antibody (TNF-alpha inhibitor) approved for the following conditions:
The intravenous formulation of Golimumab is additionally approved, in some markets, for polyarticular juvenile idiopathic arthritis and pediatric psoriatic arthritis in patients 2 years of age and older (guideline/label-supported pediatric extension; see Use in Special Populations). Golimumab is not indicated for infectious or non-autoimmune forms of arthritis.
| Indication | Route | Dose |
|---|---|---|
| Rheumatoid arthritis (with methotrexate) | Subcutaneous | 50 mg once monthly, same date each month |
| Psoriatic arthritis | Subcutaneous | 50 mg once monthly |
| Ankylosing spondylitis | Subcutaneous | 50 mg once monthly |
| Ulcerative colitis - Induction | Subcutaneous | 200 mg at Week 0, then 100 mg at Week 2 |
| Ulcerative colitis - Maintenance | Subcutaneous | 100 mg every 4 weeks (50 mg every 4 weeks if body weight <80 kg, per treating physician's assessment) |
| RA / PsA / AS (intravenous formulation) | Intravenous infusion | 2 mg/kg at Weeks 0 and 4, then every 8 weeks, infused over 30 minutes |
All doses of Golimumab above 50 mg (subcutaneous, for patients weighing more than 100 kg) or as clinically indicated should be individualised by the treating physician. See Dosage, Administration, and Duration of Treatment sections for further detail.
Common (may affect more than 1 in 10-100 people):
Serious (less common but clinically important):
See Precautions and Warnings for details on monitoring for these serious effects during treatment with Golimumab.
See Precautions and Warnings for infection screening requirements (latent tuberculosis, hepatitis B) that must be completed before initiating Golimumab.
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.